Pharmaceuticals

The pharmaceutical industry is a EUR 1 trillion sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.
Page 3/16
Category Tools

Moberg Derma AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Takeda Pharmaceuticals North America, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Micromet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Abbott Laboratories - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

SXC Health Solutions Corp. (formerly Systems Xcellence, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Tesco PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Luminex Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Patheon, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Eurand N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Jubilant Life Sciences Limited (formerly known as Jubilant Organosys, Ltd.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Rosetta Genomics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

United Therapeutics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Astellas Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sun Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

MEDNAX, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Kindred Healthcare, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Labopharm, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cancer Research Technology Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Eisai, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sarepta Therapeutics, Inc. (Formerly AVI BioPharma, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

QRxPharma Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Asuragen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Wright Medical Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cardium Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Glenmark Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Profectus BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Nuvo Research, Inc. (formerly Dimethaid Research, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Boston Scientific Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Dr. Reddy's Laboratories, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Actavis Group hf (formerly Pharmaco Hf) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

VHA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Merit Medical Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Centene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Siemens Healthcare Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

454 Life Sciences - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Syneron Medical, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

MorphoSys AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

SciClone Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Morphotek, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Fujirebio, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Baxter International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Nycomed International Management GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Albany Molecular Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

RadNet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Golden Meditech Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Emergent Biosolutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Proximagen Neuroscience plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Genentech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Options